Is children's asthma made worse by inhalers?
Conclusion
This proof-of-concept trial suggests that montelukast offers a more effective treatment option than salmeterol in a group of children with poorly controlled asthma and a specific genetic variation.
The researchers concluded that “adding montelukast to inhaled fluticasone significantly reduced school absences, improved asthma symptoms and quality-of-life, while reducing inhaled reliever use” compared to salmeterol. They also say that “the relative benefits of montelukast in comparison to salmeterol became evident within the first three months and persisted throughout the whole year.” They suggest that th...
Source: NHS News Feed - January 8, 2013 Category: Consumer Health News Tags: Heart/lungs Pregnancy/child Source Type: news
